Skip to main content UK The UK's free public sector contract intelligence platform. 160,000+ live opportunities from every official UK procurement portal.
PA23 Ready UK Data Daily Updates
BidWriter Found a contract? BidWriter drafts, scores and manages the bid — AI bid writing from your own evidence.
eSourcing OS For buyers. The platform contracting authorities run their tenders, frameworks and DPS on.
See eSourcing OS → 🇺🇸 WinAContract InternationalBidding on US federal & state contracts? Use our American platform:
© 2026 eSourcing Data Ltd · Company No. 16391108 Registered in England & Wales
Data sourced under Crown Copyright from official UK government portals 🇬🇧
Loading contract search results…
Loading contract details…
#2c3e50#3aaee0
Awarded: NHS Framework Agreement for Branded medicines | Thornton and Ross Ltd | WinAContract
Award outcome Awarded to (86 suppliers)
Thornton and Ross Ltd GB-CFS-165045
Selective Supplies Ltd. GB-CFS-209835
Teva UK Limited GB-CFS-209836
Wockhardt UK Limited GB-CFS-186547
Martindale Pharma GB-CFS-186541
Thea Pharmaceuticals Limited GB-CFS-209837
Merck Sharpe & Dohme (UK) Limited GB-CFS-183732
Norgine Pharmaceuticals Limited GB-CFS-209838
Kent Pharma Ltd GB-CFS-186542
Description NHS Framework Agreement for Branded medicines - National
FIND A TENDER (FTS) Reference number FTS-003607
Offer reference number CM/PHR/21/5643 NHS Framework Agreement for Branded Medicines - National
Period of Framework: 1 May 2022 to 30 April 2024
About NHS England Published contracts in the last 12 months
£251,986,446
average contract size
Typical categories
Education and training services Medical equipments, pharmaceuticals and personal care products
Add to pipelineImports the contract into your BidWriter pipeline · Qualify before you commit to bid
Save Alert me Share this contractApplication Deadline
9 December 2021
Closed
Estimated Value
£526,000,000
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation → Contract Duration: 2.0 years
Procurement ID (OCID): ocds-b5fd17-f7e5581c-3416-4790-902f-48bbb0fb5223
Notice Reference: 0e2151e3-7662-46b2-9479-c5fa4025b150-640244
Tillomed Laboratories ltd
GB-CFS-186545
Roche Products Ltd GB-CFS-183739
Dexcel Pharma Ltd GB-CFS-186553
Rosemont Pharmaceuticals Limited GB-CFS-209840
Recordati Rare Diseases UK Ltd GB-CFS-209841
Intrapharm Laboratories Ltd GB-CFS-209842
Accord-UK Ltd GB-CFS-183727
GlaxoSmithKline UK Limited GB-CFS-198842
Drugsrus Ltd GB-CFS-209844
ennogen healthcare ltd GB-CFS-209845
mibe Pharma UK Ltd GB-CFS-209846
Cambridge Healthcare Supplies Ltd GB-CFS-209847
Morningside Pharmaeuticals GB-CFS-183759
Dr Falk Pharma UK Ltd GB-CFS-209848
Mercury Pharmaceuticals Limited GB-CFS-209849
Fresenius Kabi Limited GB-CFS-209850
Novo Nordisk GB-CFS-183735
Neon Healthcare Ltd GB-CFS-209851
Tillotts Pharma UK Ltd GB-CFS-209852
Napp Pharmaceuticals Ltd GB-CFS-183734
Takeda UK Ltd GB-CFS-183750
Day Lewis Medical Ltd GB-CFS-186550
B. Braun Medical Limited GB-CFS-181856
Aguettant Ltd GB-CFS-209853
Ferring Pharmaceuticals Ltd GB-CFS-183751
Aventis Pharma ltd t/a Sanofi GB-CFS-183752
Baxter Healthcare Ltd GB-CFS-209854
Colonis Pharma Ltd GB-CFS-209855
Eli Lilly & Company Ltd GB-CFS-183747
Reckitt Benckiser GB-CFS-209856
Crescent Pharma Ltd GB-CFS-209857
CST Pharma Limited GB-CFS-183757
Janssen-Cilag Ltd GB-CFS-209858
Aspire Pharma Limited GB-CFS-186556
FLYNN PHARMA LTD GB-CFS-186554
Chiesi Limited GB-CFS-186555
Ferndale Pharmaceuticals Ltd GB-CFS-209860
LogixX Pharma Ltd GB-CFS-209861
Clinigen Healthcare Limited GB-CFS-209862
AOP Orphan Ltd GB-CFS-209863
Aspen Pharmacare UK Limited GB-CFS-186543
Glenmark Pharmaceuticals Europe Limited GB-CFS-186544
Organon Pharmaceuticals UK Ltd GB-CFS-183742
Zentiva Pharma UK Ltd GB-CFS-165046
ORPHALAN UK LTD GB-CFS-209864
Fontus Health Ltd GB-CFS-209865
Univar Solutions GB-CFS-209866
Roma Pharmaceuticals Limited GB-CFS-209867
Alliance Pharmaceuticals Limited GB-CFS-209868
Lupin Healthcare (UK) Limited GB-CFS-209869
Cenote Pharma Limited GB-CFS-209870
Kyowa Kirin Ltd GB-CFS-209871
Biofrontera Pharma GmbH GB-CFS-209872
Pharmacosmos UK Ltd GB-CFS-183753
Stirling Anglian Pharmaceuticals Ltd GB-CFS-209874
Strides Pharma Uk LTD GB-CFS-209875
Karo Pharma UK Ltd GB-CFS-209876
Rayner Surgical Group Ltd GB-CFS-209877
Galen Limited GB-CFS-209878
Oralieve UK Ltd GB-CFS-209879
Opella Healthcare UK LTD GB-CFS-209881
Torrent Pharma UK Ltd GB-CFS-209882
Necessity Supplies Limited GB-CFS-209883
Focus Pharmaceuticals Ltd GB-CFS-209884
EVER Pharma UK Ltd. GB-CFS-209887
Award value: £526,000,000 Award decision date: 15 May 2022 Award status: Active